G-CSF increases mesenchymal precursor cell numbers in the bone marrow via an indirect mechanism involving osteoclast-mediated bone resorption

Stem Cell Research

Volumn 5, Issue 1, 2010, Pages 65-75

  Brouard, Nathalie ^a,b   Driessen, Rebecca ^b   Short, Brenton ^b   Simmons, Paul J ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; OSTEOPROTEGERIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE TURNOVER; CELL COUNT; CELL EXPANSION; CELL PROLIFERATION; COLONY FORMING CELL; CONTROLLED STUDY; FIBROBLAST; HEMATOPOIETIC STEM CELL; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; STEM CELL MOBILIZATION; TIME;

ANIMALS; BONE MARROW; BONE RESORPTION; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; GRANULOCYTE COLONY-STIMULATING FACTOR; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; OSTEOCLASTS; OSTEOGENESIS;

MUS;

EID: 77953289387     PISSN: 18735061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scr.2010.04.002     Document Type: Article

References (54)

1. Arai F., Hirao A., Ohmura M., Sato H., Matsuoka S., Takubo K., Ito K., Koh G.Y., and Suda T. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118 (2004) 149-161
2. Ben-Ishay Z., Prindull G., Sharon S., and Borenstein A. Pre-CFU-f: young-type stromal stem cells in murine bone marrow following administration of DNA inhibitors. Int. J. Cell Cloning 4 (1986) 126-134
3. Berry M.F., Engler A.J., Woo Y.J., Pirolli T.J., Bish L.T., Jayasankar V., Morine K.J., Gardner T.J., Discher D.E., and Sweeney H.L. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H2196-H2203
4. Bianco P., Robey P.G., and Simmons P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2 (2008) 313-319
5. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., Martin R.P., Schipani E., Divieti P., Bringhurst F.R., Milner L.A., Kronenberg H.M., and Scadden D.T. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
6. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellantuono I., and Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98 (2001) 2396-2402
7. Caplan A.I., and Dennis J.E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98 (2006) 1076-1084
8. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P.N., Traas J., Schugar R., Deasy B.M., Badylak S., Buhring H.J., Giacobino J.P., Lazzari L., Huard J., and Peault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3 (2008) 301-313
9. da Silva Meirelles L., Sand T.T., Harman R.J., Lennon D.P., and Caplan A.I. MSC frequency correlates with blood vessel density in equine adipose tissue. Tissue Eng. A 15 2 (2009) 221-229
10. Dexter T.M. Haemopoiesis in long-term bone marrow cultures. A review. Acta Haematol. 62 (1979) 299-305
11. Doucet C., Ernou I., Zhang Y., Llense J.R., Begot L., Holy X., and Lataillade J.J. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. J. Cell. Physiol. 205 2 (2005) 228-236
12. Erices A., Conget P., and Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 109 (2000) 235-242
13. Feng S.W., Lu X.L., Liu Z.S., Zhang Y.N., Liu T.Y., Li J.L., Yu M.J., Zeng Y., and Zhang C. Dynamic distribution of bone marrow-derived mesenchymal stromal cells and change of pathology after infusing into mdx mice. Cytotherapy 10 (2008) 254-264
14. Fernandez M., Simon V., Herrera G., Cao C., Del Favero H., and Minguell J.J. Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients [see comments]. Bone Marrow Transplant. 20 (1997) 265-271
15. Fouillard L., Chapel A., Bories D., Bouchet S., Costa J.M., Rouard H., Herve P., Gourmelon P., Thierry D., Lopez M., and Gorin N.C. Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia 21 (2007) 568-570
16. Friedenstein A.J., Chailakhyan R.K., and Gerasimov U.V. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 20 (1987) 263-272
17. Giordano A., Galderisi U., and Marino I.R. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J. Cell. Physiol. 211 (2007) 27-35
18. Grigoriadis A.E., Heersche J.N., and Aubin J.E. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J. Cell Biol. 106 (1988) 2139-2151
19. Gronthos S., and Simmons P.J. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85 (1995) 929-940
20. Gronthos S., and Simmons P.J. The biology and application of human bone marrow stromal cell precursors. J. Hematother. 5 (1996) 15-23
21. Gutierrez-Rodriguez M., Reyes-Maldonado E., and Mayani H. Characterization of the adherent cells developed in Dexter-type long-term cultures from human umbilical cord blood. Stem Cells 18 (2000) 46-52
22. Huss R., Lange C., Weissinger E.M., Kolb H.J., and Thalmeier K. Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells 18 (2000) 252-260
23. Joo S.Y., Cho K.A., Jung Y.J., Kim H.S., Park S.Y., Choi Y.B., Hong K.M., Woo S.Y., Seoh J.Y., Cho S.J., and Ryu K.H. Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner. Cytotherapy 12 (2010) 361-370
24. Kassis I., Zangi L., Rivkin R., Levdansky L., Samuel S., Marx G., and Gorodetsky R. Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant. 37 (2006) 967-976
25. Katayama Y., Battista M., Kao W.M., Hidalgo A., Peired A.J., Thomas S.A., and Frenette P.S. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124 (2006) 407-421
26. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 142 (2001) 5050-5055
27. Kollet O., Dar A., Shivtiel S., Kalinkovich A., Lapid K., Sztainberg Y., Tesio M., Samstein R.M., Goichberg P., Spiegel A., Elson A., and Lapidot T. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12 (2006) 657-664
28. Kuznetsov S., and Gehron Robey P. Species differences in growth requirements for bone marrow stromal fibroblast colony formation In vitro. Calcif. Tissue Int. 59 (1996) 265-270
29. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., and Robey P.G. Circulating skeletal stem cells. J. Cell Biol. 153 (2001) 1133-1140
30. Lazarus H.M., Haynesworth S.E., Gerson S.L., and Caplan A.I. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J. Hematother. 6 (1997) 447-455
31. Liu Q.H., Cheng F.J., Chen L., Tang J.M., Wang J.N., and Gao Q.P. Effects of rhG-CSF on mobilization of mouse mesenchymal stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15 (2007) 790-794
32. Lund T.C., Tolar J., and Orchard P.J. Granulocyte colony-stimulating factor mobilized CFU-F can be found in the peripheral blood but have limited expansion potential. Haematologica 93 (2008) 908-912
33. Maloney M.A., Lamela R.A., and Patt H.M. The question of bone marrow stromal fibroblast traffic. Ann. N.Y. Acad. Sci. 459 (1985) 190-197
34. Mansilla E., Marin G.H., Drago H., Sturla F., Salas E., Gardiner C., Bossi S., Lamonega R., Guzman A., Nunez A., Gil M.A., Piccinelli G., Ibar R., and Soratti C. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant. Proc. 38 (2006) 967-969
35. Markov V., Kusumi K., Tadesse M.G., William D.A., Hall D.M., Lounev V., Carlton A., Leonard J., Cohen R.I., Rappaport E.F., and Saitta B. Identification of cord blood-derived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles. Stem Cells Dev. 16 (2007) 53-73
36. Molineux G., Pojda Z., and Dexter T.M. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 75 (1990) 563-569
37. Nervi B., Link D.C., and DiPersio J.F. Cytokines and hematopoietic stem cell mobilization. J. Cell. Biochem. 99 (2006) 690-705
38. Porada C.D., Zanjani E.D., and Almeida-Porad G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr. Stem Cell Res. Ther. 1 (2006) 365-369
39. Rochefort G.Y., Delorme B., Lopez A., Herault O., Bonnet P., Charbord P., Eder V., and Domenech J. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 24 (2006) 2202-2208
40. Sakaguchi Y., Sekiya I., Yagishita K., and Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Rheum. 52 (2005) 2521-2529
41. Semerad C.L., Christopher M.J., Liu F., Short B., Simmons P.J., Winkler I., Levesque J.P., Chappel J., Ross F.P., and Link D.C. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106 (2005) 3020-3027
42. Short B.J., Brouard N., and Simmons P.J. Prospective isolation of mesenchymal stem cells from mouse compact bone. Meth. Mol. Biol. 482 (2009) 259-268
43. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Colombero A., Tan H.L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T.M., Hill D., Pattison W., Campbell P., Sander S., Van G., Tarpley J., Derby P., Lee R., and Boyle W.J. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
44. Spaeth E., Klopp A., Dembinski J., Andreeff M., and Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 15 (2008) 730-738
45. Sudo Y., Shimazaki C., Ashihara E., Kikuta T., Hirai H., Sumikuma T., Yamagata N., Goto H., Inaba T., Fujita N., and Nakagawa M. Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice. Blood 89 (1997) 3186-3191
46. Takahashi T., Wada T., Mori M., Kokai Y., and Ishii S. Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice. Lab. Investig. 74 (1996) 827-834
47. Takamatsu Y., Simmons P.J., Moore R.J., Morris H.A., To L.B., and Levesque J.P. Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood 92 (1998) 3465-3473
48. Toma J.G., Akhavan M., Fernandes K.J., Barnabé-Heider F., Sadikot A., Kaplan D.R., and Miller F.D. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3 (2001) 778-784
49. Tyndall A., Walker U.A., Cope A., Dazzi F., De Bari C., Fibbe W., Guiducci S., Jones S., Jorgensen C., Le Blanc K., Luyten F., McGonagle D., Martin I., Bocelli-Tyndall C., Pennesi G., Pistoia V., Pitzalis C., Uccelli A., Wulffraat N., and Feldmann M. Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res. Ther. 9 (2007) 301
50. Uccelli A., Moretta L., and Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8 (2008) 726-736
51. Wagner W., Wein F., Seckinger A., Frankhauser M., Wirkner U., Krause U., Blake J., Schwager C., Eckstein V., Ansorge W., and Ho A.D. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp. Hematol. 33 (2005) 1402-1416
52. Yan Y., Xu W., Qian H., Si Y., Zhu W., Cao H., Zhou H., and Mao F. Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int. 29 3 (2009) 356-365
53. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., Fraser J.K., Benhaim P., and Hedrick M.H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13 (2002) 4279-4295
54. Zvaifler N.J., Marinova-Mutafchieva L., Adams G., Edwards C.J., Moss J., Burger J.A., and Maini R.N. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2 (2000) 477-488